We are ViiV Healthcare – the only global pharma 100% dedicated to preventing, treating & curing HIV.
Unafraid to be first we bring together our transformational science and a deep understanding of the communities we serve – all to make HIV history.
10/03/2026
National Women and Girls HIV/AIDS Awareness Day in the U.S. is a vital moment to confront HIV stigma head-on. The first step is to educate and correct common misconceptions surrounding women and HIV.
Click through to learn the facts and break the stigma.
26/02/2026
We remain committed to helping communities most impacted by HIV. That’s why we won’t stop pushing science forward, strengthening partnerships and advocating for meaningful change. ✅
We reaffirm our dedication to addressing health disparities this Black History Month and beyond – because we’re here until HIV isn’t. 💪
Click through to learn more about our commitment to the Black community.
10/02/2026
"My wish really for every person living with HIV is that it becomes an afterthought.”
We’re committed to turning this wish into reality by providing people living with HIV a variety of treatment options that best fit their needs. ✅
Watch to hear more about this powerful vision.
27/01/2026
Positive Action (Global) invites applications aimed at scaling up community-based, evidence-informed interventions that support locally led programmes to enhance paediatric HIV testing coverage, strengthen linkage to care, and improve viral suppression rates in Angola, Cameroon, Democratic Republic of Congo, Mozambique, and Tanzania.
Ever heard of U=U? 🤔 It's a powerful tool that has helped combat stigma and prevent the transmission of HIV. Click through to learn more.
22/01/2026
You are the expert on you. ✨
Watch Dr. Kimberly Smith and Raif Derrazi dive into a crucial truth: HIV care isn't just about the virus. It impacts you physically, mentally, emotionally, and sexually. 💖
As Raif puts it, when HIV treatment works well, it 'fades into the background,' allowing individuals to thrive. 🙏
We're dedicated to advancing care that meets the different wants and needs of people living with HIV.
Watch the full discussion through the link in bio!
16/01/2026
Women are left out of the conversation all too often.
We need to make HIV prevention a topic that is easily talked about, reflecting how we truly live. That means recognising that prevention can look different for everyone.
That is exactly why we launched Risk to Reasons.
Together with the working group, we were able to create useful guides for women and healthcare professionals across the UK.
These guides will support open, non-judgmental, and proactive conversations about HIV prevention and care.
15/01/2026
Innovation in HIV treatment is transforming lives! ✨
We're seeing more flexible options and a better quality of life for people living with HIV.
Hear from Dr. Kimberly Smith and Raif Derrazi on why innovation, paired with a strong patient-doctor relationship, is so vital. 🤝
Watch the full discussion through the link in bio!
14/01/2026
We believe in the power of community-led solutions. 💪
With our Risk to Reasons initiative in the US, we are taking the lived experiences of Black women and turning them into new ways of viewing HIV prevention and care.
You can’t treat HIV in isolation — it affects the physical, mental, emotional and sexual parts of life. Dr. Kimberly Smith and Raif Derrazi highlight that when treatment is doing its job, it should fade into the background so people can start feeling good about their lives. ✨
Watch the full video through the link in bio to hear this lived‑experience perspective.
17/12/2025
Don’t let misinformation stand in the way of your health! Click through to dispel myths and learn real facts about PrEP.
16/12/2025
Together, we can make HIV history. 🤝
This year, we brought together HIV advocates, public health partners, grassroots organizers and community leaders in Phoenix, Montreal, and Portugal to listen, learn and act on our mission to end HIV.
Witness the global movement – watch to see highlights from Patient and Community Summits across the globe.
Be the first to know and let us send you an email when ViiV Healthcare posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
At ViiV Healthcare we do things differently. From our unique origins to our innovative medicines, we push the boundaries of what people think is possible in HIV treatment and care.
If you should know one thing about us, know this: we will not rest until we leave no person living with #HIV (PLHIV) behind. Until the 37 million PLHIV is down to zero, we will continue searching for new ways to limit the impact of HIV.[1]
Born out of a partnership between GSK and Pfizer in 2009, with Shionogi joining in 2012, at ViiV Healthcare we are determined to help end the HIV epidemic. Our one focused goal unites our 1100 employees located across over 20 countries, with their expertise in research, manufacturing, policy and more, all guided by our mission to be here until HIV isn’t.
Our current portfolio of 14 HIV treatments is our first step in fighting back against the disease. This is only the beginning as our research centre in Branford, Connecticut, the world’s only HIV-dedicated facility, is utterly focused on finding new innovative medicines to help improve the lives of PLHIV.
Also searching to find major breakthroughs against HIV is our industry-defining partnership with the HIV Cure Centre at the University of North Carolina. Part of a unique public-private collaboration ‘Qura Therapeutics’, we have been combining resources and expertise to accelerate novel breakthroughs and maximise the chance of finding a HIV cure.
Alongside our novel approach to R&D, improving access to medicines is just as important in delivering results for our patients.
At ViiV Healthcare we are dedicated to widening access to ensure those who need our medicines can receive them. Collaborations with organisations such as IAS, CHAI and MPP enable our medicines to make the greatest possible impact in countries around the world.
As an example, our voluntary licence agreements allow generic manufacturers to develop paediatric formulations of our medicines where 99% of children living with HIV live. We are committed to working ever closer with our partners through continued access initiatives.
To accelerate the eradication of HIV once and for all, we put significant focus on community initiatives to strengthen local healthcare services for PLHIV.
Through our Positive Action programmes which back over 300 projects worldwide, our work with local communities aim to deliver long-lasting impacts on groups such as women and children. We seek to enhance local expertise and resources that build towards global goals including the WHO 90-90-90 targets, as well as our own dedicated mission of leaving no person living with HIV behind.[2]
[1] Global Health Observatory (GHO) data – HIV/AIDs. Available from: https://www.who.int/gho/hiv/en/. Last accessed: February 2019
